Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wael El-Rifai

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Oncotarget|January 17, 2015
Advances in targeted therapies and new promising targets in esophageal cancerAbbes Belkhiri, Wael El-Rifai
Gut|July 2, 2013
5-Methylcytosine hydroxylation-mediated LINE-1 hypomethylation: a novel mechanism of proto-oncogenes activation in colorectal cancer?Abbes Belkhiri, Wael El-Rifai
Gastroenterology|July 12, 2011
DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinibShoumin Zhu, Abbes Belkhiri, Wael El-Rifai
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 20, 2008
Therapeutic prospects for p73 and p63: rising from the shadow of p53Anna Vilgelm, Wael El-Rifai, Alexander Zaika
Oncotarget|February 13, 2016
DARPP-32: from neurotransmission to cancerAbbes Belkhiri, Shoumin Zhu, Wael El-Rifai
Gastroenterology|November 18, 2022
ReplyMohammed Soutto, Xing Zhang, Wael El-Rifai
Gastroenterology|June 27, 2022
ReplyLonglong Cao, Heng Lu, Wael El-Rifai
Molecular Cancer|May 20, 2015
Aurora kinase A in gastrointestinal cancers: time to targetAhmed Katsha, Abbes Belkhiri, Laura Goff, et al.
Redox Biology|February 23, 2021
The antioxidant response in Barrett's tumorigenesis: A double-edged swordDunfa Peng, Alexander Zaika, Jianwen Que, et al.
Cancer Research|September 18, 2004
p73 isoforms can induce T-cell factor-dependent transcription in gastrointestinal cellsKatarina Tomkova, Abbes Belkhiri, Wael El-Rifai, et al.
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Oncotarget|January 17, 2015
Advances in targeted therapies and new promising targets in esophageal cancerAbbes Belkhiri, Wael El-Rifai
Gut|July 2, 2013
5-Methylcytosine hydroxylation-mediated LINE-1 hypomethylation: a novel mechanism of proto-oncogenes activation in colorectal cancer?Abbes Belkhiri, Wael El-Rifai
Gastroenterology|July 12, 2011
DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinibShoumin Zhu, Abbes Belkhiri, Wael El-Rifai
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 20, 2008
Therapeutic prospects for p73 and p63: rising from the shadow of p53Anna Vilgelm, Wael El-Rifai, Alexander Zaika
Oncotarget|February 13, 2016
DARPP-32: from neurotransmission to cancerAbbes Belkhiri, Shoumin Zhu, Wael El-Rifai
Gastroenterology|November 18, 2022
ReplyMohammed Soutto, Xing Zhang, Wael El-Rifai
Gastroenterology|June 27, 2022
ReplyLonglong Cao, Heng Lu, Wael El-Rifai
Molecular Cancer|May 20, 2015
Aurora kinase A in gastrointestinal cancers: time to targetAhmed Katsha, Abbes Belkhiri, Laura Goff, et al.
Redox Biology|February 23, 2021
The antioxidant response in Barrett's tumorigenesis: A double-edged swordDunfa Peng, Alexander Zaika, Jianwen Que, et al.
Cancer Research|September 18, 2004
p73 isoforms can induce T-cell factor-dependent transcription in gastrointestinal cellsKatarina Tomkova, Abbes Belkhiri, Wael El-Rifai, et al.
Pageof 16